Angola vs Slovenia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Angola
54.0%
in 2025
Slovenia
55.0%
in 2025
Angola rank
151st
Slovenia rank
150th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Angola
- Slovenia
How they compare
Slovenia currently reports 55.0% against 54.0% in Angola, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Slovenia ahead.
Angola ranks 151st and Slovenia ranks 150th of 192 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Slovenia in 1.
Head to head by decade
| Decade | Angola | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 35.9% | 28.0% | 7.9% | Angola |
| 2020s | 53.3% | 59.7% | 6.3% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Angola or Slovenia?
- Slovenia, at 55.0% against 54.0% in Angola as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Angola and Slovenia?
- 1.0%, with Slovenia ahead.
- How many years of comparable data are there for Angola and Slovenia?
- 18 years are reported by both, from 2008 to 2025.
- How do Angola and Slovenia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Angola ranks 151st and Slovenia ranks 150th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.